Hettich successfully completes acquisition of Kirsch Medical

05-Jan-2024

from left Dr. Jochen Kopitzke, Managing Director of Philipp Kirsch GmbH, Kristina Eberle & Klaus-Günter Eberle, Managing Directors of Andreas Hettich GmbH & Co. KG

In 2023, Hettich Group experienced its most lucrative year yet in its 120-year history. For the first time, the Tuttlingen-based company, specializing in centrifuges and incubators for clinical-medical applications across three European locations, significantly surpassed the 100 million euro threshold in revenue. In addition to this outstanding organic growth, the strategic growth trajectory was further propelled by an acquisition.

The 100% acquisition of Philipp Kirsch GmbH by the Hettich Group marks a significant milestone for both entities. Based in Willstätt-Sand, Germany the Philipp Kirsch GmbH is a renowned manufacturer of high-quality cooling and freezing solutions for laboratories and healthcare, setting standards in quality and reliability since 1865.

"Our similar business philosophy and corporate culture, characterized by a high understanding of quality, long-term thinking and action, as well as the appreciation of our employees and business partners, form the foundation of this strategic partnership," stated Dr. Jochen Kopitzke, who will continue as Managing Director of Philipp Kirsch GmbH.

The synergy effects of this acquisition across the entire value chain are diverse. Given the substantial overlap in target markets between both companies, the focus is on the potential of cross-selling to streamline and expand distribution channels more efficiently. Particularly, Hettich's strong international network, comprising 6 subsidiaries and over 100 established global partners, will create opportunities significantly boosting revenue and outcomes.

"The Hettich Group will experience substantial growth, and this union provides us with the opportunity to challenge existing practices, learn together, and openly develop new perspectives," added Klaus-Günter Eberle, Managing Director of the Hettich Group. "A merger of two family-owned businesses is no longer commonplace. Yet, we see this as our future strength. We aim to synergistically evolve ‘the best of both worlds’ and proceed in a goal-oriented manner after both sides have had sufficient opportunity to get to know each other," remarked Managing Director Kristina Eberle.

The management of both companies eagerly anticipate continuing the success story and enhancing competitive prowess. The primary focus is to offer customers worldwide a broader portfolio of high-quality laboratory products and services.

https://www.analytica-world.com/en/news/1182379/hettich-successfully-completes-acquisition-of-kirsch-medical.html

Topics

centrifuges incubators takeovers lab equipment laboratory centrifuges laboratory incubators cooling devices freezing systems laboratory facilities

Show all

Organizations

Hettich

Philipp Kirsch

See the theme worlds for related content

Topic world Centrifugation

Centrifugation is an indispensable process in the life sciences. By using centrifugal forces, it enables the separation of cells, proteins and other biomolecules according to size and density. Whether in the purification of therapeutic proteins, the isolation of DNA/RNA or the separation of cell cultures - centrifugation plays a central role in biological and pharmaceutical research and production.

1 products

View topic world